Cargando…
Utility of polygenic embryo screening for disease depends on the selection strategy
Polygenic risk scores (PRSs) have been offered since 2019 to screen in vitro fertilization embryos for genetic liability to adult diseases, despite a lack of comprehensive modeling of expected outcomes. Here we predict, based on the liability threshold model, the expected reduction in complex diseas...
Autores principales: | Lencz, Todd, Backenroth, Daniel, Granot-Hershkovitz, Einat, Green, Adam, Gettler, Kyle, Cho, Judy H, Weissbrod, Omer, Zuk, Or, Carmi, Shai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8510582/ https://www.ncbi.nlm.nih.gov/pubmed/34635206 http://dx.doi.org/10.7554/eLife.64716 |
Ejemplares similares
-
Screening Embryos for Polygenic Conditions and Traits: Ethical Considerations for an Emerging Technology
por: Lázaro-Muñoz, Gabriel, et al.
Publicado: (2020) -
Divergence Between Clinician and Patient Perspectives on Polygenic Embryo Screening: A Qualitative Study
por: Barlevy, Dorit, et al.
Publicado: (2023) -
Polygenic susceptibility to prostate and breast cancer: implications for personalised screening
por: Pashayan, N, et al.
Publicado: (2011) -
Nomograms of human hippocampal volume shifted by polygenic scores
por: Janahi, Mohammed, et al.
Publicado: (2022) -
Polygenic susceptibility to testicular cancer: implications for personalised health care
por: Litchfield, Kevin, et al.
Publicado: (2015)